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Abstract The significant differences in the metastatic proper-
ties of hamster fibroblasts transformed by the Rous sarcoma
virus (RSV) were associated with mutations in the v-src carboxy-
terminal region. To identify the capacity of this region for
protein^protein interaction the two-hybrid system was used. The
cDNA clone (vseap1), producing the protein specifically bound
with the v-src C-terminal part in yeast cells in vivo and in GST-
fusion system in vitro was isolated. Vseap1 shared 68% of
homology with stressful agents induced RNA-gadd7/adapt15.
Two vseap1 specific messenger RNAs were identified: 0.9-kbp
RNA expressed in all transformed cells and three times less in
embryo fibroblasts; 3.1-kbp transcript was deleted in the cells
with suppressed v-src activity and H2O2 resistance.
z 1998 Federation of European Biochemical Societies.
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1. Introduction
V-src oncogene of RSV and its cellular counterpart c-src are
membrane-associated phosphoproteins with tyrosine-speci¢c
kinase activity. The role of src in cell adhesion, cytoskeletal
changes and motility depends upon its cellular localization
and state of activity. The src protein is structured in several
functional domains [1^3]. The major di¡erence between v-src
and c-src resides at the carboxy ends of the proteins. The last
19 aa of c-src contain a tyrosine residue at position 527. This
residue, when phosphorylated, down-regulates c-src kinase ac-
tivity [4]. In v-src the last aa are replaced by a tail of 12 aa
generated as a result of recombination events between the 3P
end of c-src and 39-bp sequence from the downstream non-
coding region [5]. The changes at the carboxy-terminal aa of
v-src do not a¡ect its kinase activity or cell transformation [6].
The function of this region is unclear.
Recently two new variants (srcHM and srcLM) of v-src
oncogene from low and highly metastastic hamster cells
were isolated [7]. These src versions have signi¢cant structural
changes that are not observed in other src genes. In the N-
terminal unique region of both HM and LM v-src isoforms a
GC-rich insert of 60 nucleotides (20 aa) was found. The pres-
ence of this insert accounts for the unusual molecular weight
of the encoded v-src protein (62 kDa). Both v-src variants
have 10 identical amino acid changes compared to the known
RSV-derived v-src sequence. The most interesting feature is
that v-srcHM and v-srcLM di¡er one from the other in sev-
eral amino acids. Most of the changes are localized in the
unique v-src domain and in the extreme carboxy-terminal re-
gion. Retroviral vectors carrying srcHM and srcLM caused
di¡erent morphological transformations of cells, and changes
of the metastatic activity in vivo. Di¡erences in the C-terminal
region of the v-src proteins were shown to be responsible for
the di¡erences in the metastatic properties of the correspond-
ing transformed hamster cells [7].
To assess the molecular mechanisms underlying the v-
srcHM speci¢c high metastatic activity or the lack of such
an activity in v-srcLM, a yeast two-hybrid system was used.
To identify cellular genes associated with the unique C-termi-
nal regions of both v-src variants, the cDNA library from
RSV-transformed parental hamster ¢broblast cell line was
constructed in yeast expression vector. By screening the
cDNA library with a v-srcHM C-terminal region as bait, sev-
eral new genes previously not known as v-src protein partners
were isolated. Here we describe one of the genes called vseap1
(v-src end associated peptide), highly homologous to gadd7/
adapt15 RNA induced by various types of stress factors as
well as by DNA damage [8,9]. Two vseap1-speci¢c RNAs (3.1
and 0.9 kb) were found in virus-transformed and spontaneous
tumor cell lines.
2. Materials and methods
2.1. Plasmid constructions
pLexA-v-srcHMC and pLexA-v-srcLMC containing the coding se-
quence of C-terminal amino acids of v-srcHM gene (amino acids 522^
546) or v-srcLM gene (amino acids 500^545) respectively inserted in
frame with LexA coding sequence were constructed in the bait plas-
mid pLex11. pLex11 is a derivative of pBTM116 with a modi¢ed
polylinker (J. Camonis and V. Jung, unpublished). pGEX-v-srcHMC
allows the expression of the v-srcHMC fused to GST. The reading
frames of fusion proteins in plasmid constructions were veri¢ed by
Sequenase sequencing kit (Amersham) using LexA-binding domain or
GST-speci¢c primers.
2.2. Hamster cDNA fusion library
RNA was isolated from low metastatic cell line of Syrian hamster
¢broblasts HET-SR [10] by direct addition of guanidinium thiocya-
nate and cesium tri£uoroacetate (RNA extraction kit, Pharmacia)
followed by puri¢cation of poly(A) RNA on oligo(dT) cellulose
column. The cDNA was synthesized using TimeSaver cDNA synthesis
kit (Pharmacia) and cloned between EcoRI and NotI sites of
pGAD3S2X, a derivative of pGAD-GH with a modi¢ed polylinker
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(J. Camonis, unpublished). ElectroMAX DH10B E. coli cells (Life
Technology) were electroporated; the complexity of the library was
1.3U106 with 75% of the clones containing an insert.
2.3. Yeast two-hybrid screening
The Saccharomyces cerevisiae L40 reporter strain (genotype: Mat a
his 3D200 trp1-901 leu2-3,112 ade 2 LYS2: :(lexAop)4-HIS3 UR-
A3: :(lexAop)8-lacZ GAL4) was used for two-hybrid screening. Yeast
growth and transformation were handled according to standard pro-
tocols [11^13]. To identify proteins that interact with v-srcHMC,
1.3U107 cells containing pLexA-v-src-HMC were transformed with
the cDNA library. Double transformants were selected for histidine
prototrophy and tested for LacZ expression by a ¢lter X-GAL assay
[14]. Total DNA from His/LacZ colonies was analyzed by PCR
with customized primers for cDNA insert. The average length of
cDNA inserts was between 700^900 bp. Positive cDNA plasmids
were recovered in E. coli strain HB 101 (which carries a leuB muta-
tion) and selection for Leu prototrophy on minimal plates [15]. To
test for the target speci¢city, primary positive library DNA was iso-
lated and used for the yeast retransformation with pLexA-v-srcHMC
or pLexA-Lamin (negative control). cDNA from 6 clones speci¢c in
protein^protein interaction (v-srcHMC versus lamin) was sequenced.
Sequences were analyzed against EMBL using the Fasta 3.0t76 search
program.
2.4. Cell lines
Spontaneously transformed Syrian hamster ¢broblasts (STHF), Sy-
rian hamster embryo ¢broblasts (HEF) and its derivatives ^ HET-SR,
HET-SR 8 (HEF, transformed independently in vitro by di¡erent
stocks of RSV Schmidt-Ruppin D stain) [10]; HET-SR N-ras trans-
fectants (HET-SR supertransfected with an activated N-ras gene mu-
tated in the 12th codon (G/A) [16] and HET-SR N-ras ‘antisense’
transfectants (HET-SR N-ras cells supertransfected with N-ras ‘anti-
sense’ construction) [17] were used. Cells were grown in Dulbecco’s
modi¢ed Eagle’s medium supplemented with 10% fetal calf serum and
100 mg/ml gentamycin at 37‡C in the presence of 5% CO2. The trans-
fectants di¡ered in the expression of v-src protein [16,17].
2.5. RNA blot hybridization
RNA was extracted from hamster ¢broblast cell lines by the gua-
nidinium thiocyanate/phenol method [18]. Samples were fractionated
in 1% agarose/formamide gel and transferred to Hybond N mem-
brane (Amersham). Filters were probed with [K-32P]dATP-labeled
vseap1 DNA obtained from pGADvseap1 cut with HindIII. Hybrid-
ization and washings were performed as described [19]. Following
autoradiography, blots were stripped and rehybridized with GAPDH
(glyceraldehyde-3-phosphate dehydrogenase) probe. Band intensities
were quanti¢ed by scanning using Image Quant program.
2.6. Immunoblotting of hybrid protein expression
Overnight yeast cells expressing hybrid proteins were grown in SC
medium, diluted up to 107 cells/ml and grown to an optical density of
0.6 at 600 nm. The cells were pelleted, washed with distilled water and
pelleted again. The pellets were frozen in liquid nitrogen and resus-
pended in SDS-sample bu¡er. Samples were lyzed by the glass beads
method [20]. Proteins were separated by SDS-PAGE (15% slab gel)
according to standard technique [21], transferred onto nitrocellulose
(BA 83, Schleicher and Schuell) and analyzed with ECL (Amersham).
Fusion proteins were detected using anti-LexA polyclonal antibodies
(a gift from P. Moreau).
2.7. In vitro translation
For in vitro transcription and translation pGAD3S2X and
pGAD3S2X-vseap1 were used as templates for PCR using a forward
primer (5P-CGAATTAACCCTCACTAAAGAAGGATGGCCAAT-
TTTAATCAAAGTGG-3P) containing the T3 promoter for T3
RNA polymerase and an ATG initiation codon) and a reverse uni-
versal M13^20 primer (5P-GTAAAACGACGGCCAG-3P). The PCR
products were puri¢ed on agarose gel (Geneclean II) and transcribed/
translated in vitro using a coupled transcription/translation mixture
(Promega). 40 WCi [35S]methionine (Amersham) for 1 Wg of DNA was
used to label the in vitro translated proteins.
2.8. GST-fusion proteins
Overnight cultures of E. coli BL21, transformed with GST or with
GST-v-srcHMC expressing plasmids were diluted in 500 ml of LB
with ampicillin (50 Wg/ml). After shaking for 90 min at 37‡C, protein
expression was induced with 0.4 mM IPTG for 3 h. Cells were pelleted
and resuspended in 10 ml lysis bu¡er (PBS, 20 mM EDTA, 2 mg/ml,
50 Wg/ml PMSF, 1% aprotinin and 2 Wg/ml leupeptin). After 10 min of
incubation and three cycles of freezing/thawing (380‡C and 55‡C,
respectively), 25 mM MgCl2, 500 mM NaCl, 1% Triton X-100 and
5 mM DTT (¢nal concentrations) were added. To reduce DNA vis-
cosity, lysates were sheared with 12^15 passages through a 21-gauge
syringe needle and clari¢ed by centrifugation. After sedimentation of
proteins on glutathione-Sepharose 4B beads (Pharmacia), beads were
washed four times with washing bu¡er (20 mM Tris-HCl, pH 7.5,
10% glycerol, 1 mM DTT, 5 mM MgCl2, 100 mM NaCl, 1% aproti-
nin, 50 Wg/ml PMSF). Purity and integrity of GST-fusion proteins
were assessed by SDS-PAGE and Coomassie Blue R staining of pro-
teins. Protein quanti¢cation was done as described [22].
2.9. Detection of GST-v-srcHMC binding with translated proteins
100 Wg of GST or of GST-v-srcHMC proteins bound to glutathione
beads were incubated with 10 Wl of the transcription/translation mix-
ture containing [35S]methionine-labeled protein in binding bu¡er (20
mM Tris-HCl, pH 7.5, 100 mM NaCl, 0.2% NP-40, 0.2 mM DTT,
protease inhibitors) for 3 h at 4‡C. The beads were washed ¢ve times
at 4‡C with 1.5 ml of binding bu¡er, boiled for 10 min in sample
bu¡er and analyzed by SDS-PAGE (17% slab gel). The gel was
stained with Coomassie Blue R, dried and exposed to an X-ray ¢lm
for 1^2 days.
3. Results
3.1. Identi¢cation of hamster cDNA encoding proteins
interacting with the C-terminal part of v-srcHMC by
two-hybrid screening
The two-hybrid system was used to determine cellular genes
associated with C-terminal region of v-srcHMC and v-srcLM
[23]. The bait hybrid proteins with C-terminal parts of v-
srcHM or v-srcLM, fused in frame with the bacterial binding
domain LexA were constructed. The second hybrid was a
panel of hamster library cDNA fragments (V106) expressed
as fusions to the GAL4 transcriptional activation domain
(GADad). Around 1.3U107 yeast colonies were screened
with pLexA-v-srcHMC, only 336 were His. Of these
57 were also LacZ. The majority of the colonies were
positive with Lex-Lamin. A speci¢c interaction with v-
srcHMC protein was found only in 6 colonies. Negative
with lamin and reproducibly positive with v-srcHMC,
cDNA clones encoding proteins were sequenced. Two out of
six cDNA clones had the same primary structure and were
designated as vseap1 gene.
3.2. Structure of vseap1
The cloned cDNA was sequenced in both directions and
had 764 bases plus poly(A) tail. A search in the GenBank
database demonstrated about 68% of homology with recently
characterized gadd7/adapt15 gene [8,9]. The homology be-
tween these genes was more signi¢cant in the 5P and 3P regions
(Fig. 1A). The presented data strongly suggest that the vseap1
sequence in Syrian hamster cell is homologous to the sequence
of the gadd7/adapt15 isolated from Chinese hamster cells.
Surprisingly, the ORF in frame with GAL4-fused protein con-
tained only 8 amino acids (Fig. 1B). The longest predicted
ORF in any frame was 44 amino acids. A consensus Kozak
box-like element at position 70, in contrast to gadd7/adapt15
was not intact: the initiating ATG was mutated (Fig. 1A). No
homology with known protein sequences was found in any of
predicted ORF of vseap1.
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3.3. Comparison of v-srcHMC and v-srcLMC interaction
with vseap1 gene encoding peptide
The ability of vseap1 peptide to interact with v-srcHMC
and v-srcLMC was tested. The speci¢c pGADvseap1 plasmid
was introduced into yeast cells in the presence of pLexA-v-
srcHMC or pLexA-v-srcLMC. The expression of fusion pro-
teins LexA-v-srcHMC and LexA-v-srcLMC, veri¢ed with
LexA polyclonal antibodies, was practically at the same level.
Vseap1 protein interacted with both v-srcHMC and v-
srcLMC (Table 1). However, we found that this interaction
was weaker with the C-terminal part of v-srcLM protein.
Probably, the relatively decreased level of interaction with v-
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Fig. 1. Structure of vseap1. A: The nucleotide sequence of the hamster gene vseap1 obtained by two-hybrid cDNA library screening is shown
in the ¢rst line (EMBL Nucleotide Sequence Database accession number AJ003192). The second line is the sequence of the gene gadd7 from
EMBL. Nucleotide similarities between vseap1 and gadd7 are indicated by stars, gaps indicated by a dash. Stop codons in frame of fusion pro-
tein are underlined. B: Inferred amino acid sequence. Stop codons and methionine residues are indicated.
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srcLMC is connected with unique amino acid changes in this
region of the v-srcLM oncoprotein [7].
3.4. Protein binding of C-terminal region of v-srcHM to
vseap1 in vitro
To verify whether the vseap1 binding to v-srcHMC ob-
tained through two-hybrid screening was speci¢c, we tested
the protein interaction in vitro. GAL4ad-vseap1 fusion pro-
tein was synthesized using corresponding pGADvseap1 frag-
ment for transcription and translation in vitro in rabbit retic-
ulocytes lysate. GAL4ad protein was also translated as a
control. V-srcHMC protein was expressed as GST-fusion pro-
tein. The puri¢ed GST-protein (as a control) or GST-v-
srcHMC fusion protein bound to the glutathione-Sepharose
beads were incubated with GAL4ad-vseap1 or GAL4ad
[35S]methionine-labeled proteins and analyzed by SDS-
PAGE (Fig. 2). Staining the gel con¢rmed that equal amounts
of GST-v-srcHMC and GST were taken for the reaction.
GAL4ad-vseap1 was not able to associate directly with pure
GST (lane 1) and neither was GST-v-srcHMC able to interact
with pure GAL4ad (lane 2). Only the C-terminal region of v-
srcHM could bind speci¢cally to the vseap1 protein (lane 3).
3.5. Vseap1 RNA analysis
Gadd7/adapt15 gene was isolated from Chinese hamster
cells on the basis of speci¢c RNA expression after UV-radia-
tion [24] or hydrogen peroxide treatment [8]. This gene was
also induced by growth arrest signals and DNA-damaging
agents [25]. The observed high steady state level of gadd7/
adapt15 mRNA was due to its increased stability in treated
cells [26]. Previously RSV-transformed Syrian hamster cells
were demonstrated to be highly resistant to H2O2 damage
[10]. This phenotype directly correlated with an increased cat-
alase activity in the cells [27]. Transfection of the cells by N-
ras oncogene was shown to induce the suppression of v-src
activity, coinciding with the decrease of H2O2 resistance and
catalase activity [16,27,28]. The steady state level of vseap1-
speci¢c RNA was analyzed in the panel of v-src transformed
hamster cells, as well as in spontaneously transformed and
normal hamster ¢broblasts (Fig. 3, Table 2). Vseap1 probe
hybridized with the main 0.9-kbp transcript in all transformed
cell lines including spontaneous tumor cells. In normal ¢bro-
blasts vseap1-RNA was less expressed (Fig. 3, lane 5). Gadd7/
adapt15-speci¢c messenger of the same size was identi¢ed in
normal as well as stress agents-treated Chinese hamster cells
[8,9]. However, vseap1 also hybridized with the additional 3.1-
kbp transcript which was not described in gadd7/adapt15
analyses. Interestingly, this RNA was reduced in cell lines
with suppressed H2O2 resistant phenotype and low catalase
activity (Fig. 3, Table 2).
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Table 1
V-srcHMC and v-srcLMC interactions with vseap1 gene encoding protein in the two-hybrid system
Binding domain Activation domain pGAD vseap1 Reporter genes expression
pLexA-Lamin 3 His
3 LacZ
pLexA-v-srcHMC ++++ His
++++ LacZ
pLexA-v-srcLMC + His
+ LacZ
C-terminal parts of v-srcHM and v-srcLM proteins were expressed as fusion proteins with LexA domain. The His3 (His) expression and L-
galactosidase activity (LacZ) are indicated. In the case of HIS3 expression (+) indicates His colonies, compared to the total quantity of yeast
transformants and (3) means no growth in the absence of histidine. In the case of LacZ expression (+) indicates the blue colored colonies compared
with the quantity of His colonies, (3) means no blue color development. His3/LacZ3 means absence of interaction.
Fig. 3. Northern blot analysis of vseap1 RNA from di¡erent cell
lines of hamster ¢broblasts. Total RNA samples were fractionated
in 1% agarose/formamide gel and transferred to Hybond N mem-
brane. The blot was hybridized with vseap1 speci¢c probe and rehy-
bridized with the GAPDH probe. Lane 1: HET-SR line (low meta-
static); lane 2: HET-SR-N-ras transfectant; lane 3: HET-SR N-ras
‘antisense’ transfectant; lane 4: HET-SR-8 line (highly metastatic);
lane 5: normal hamster ¢broblasts ; lane 6: cell line obtained from
spontaneous hamster tumor.
Fig. 2. Protein binding of C-terminal region of v-srcHM to vseap1
in vitro. Puri¢ed GST or GST-v-srcHMC (approximately 100 Wg)
proteins were precipitated with 35S-labeled GAL4ad or GAL4ad-
vseap1 translated proteins as described. Precipitates were separated
on 17% SDS-PAGE. Autoradiograph of the dry gel is presented.
Lane 1: GAL4ad-vseap1+GST; lane 2: GAL4ad+GST-v-srcHMC;
lane 3: GAL4ad-vseap1+GST-v-srcHMC; lane 4: GAL4ad+GST.
The positions of GST and GST-fusion protein are indicated by ar-
rows.
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4. Discussion
The function of C-terminal region of v-src oncoprotein was
analyzed by studying the possibility for this region to interact
speci¢cally with the other proteins. The study is based on two
premises: (a) this region is very conserved in all known v-src
genes [3] ; (b) the observation that the mutations in this area
are associated with the di¡erences in the metastatic potential
of the transformed hamster cells [7].
Using a two-hybrid screening of hamster cDNA library and
a GST-fusion protein system the C-terminal aa of v-src (at
least in vitro) were found to have the capacity to interact
directly with other proteins. Several genes coding such pro-
teins were isolated. One of the identi¢ed genes, called vseap1,
is related to a member of growth arrest and DNA-damage
inducible genes gadd7/adapt15 [8,9,24]. These genes are rap-
idly induced in hamster cells by UV-radiation, by H2O2 treat-
ment or after DNA-damaging agents and certain growth ar-
rest treatment [8,25]. Modulation of gadd genes expression
speci¢cally protects the cells against di¡erent stressful signals
and is involved in adaptative response. We also observed the
activation of vseap1 in tumor cells, in comparison with nor-
mal cells : whether being virus-transformed or spontaneously
transformed. In contrast to gadd7/adapt15, two RNAs specif-
ic for vseap1 (3.1 kbp minor and 0.9 kbp major) were found.
The expression of long 3.1-kbp transcript correlates with the
level of H2O2 resistance and catalase activity of the cells.
Probably, vseap1 is involved in the mechanisms of cell anti-
oxidant defense. Moreover the expression of this gene is
stimulated in the hamster cells resistant to Q-radiation (Mu-
satkina, Tirsvina, personal communication).
The main enigma of vseap1 and gadd7/adapt15 is the con-
tradiction between the biological properties exerted by these
genes and the lack of genuine protein products. No signi¢cant
ORF was shown both for vseap1 and gadd7/adapt15. The
interaction with v-src was due to 8 amino acids coded by 5P
nucleotides of cloned sequence. We suggest that this region
represents only one part of a longer gene. According to the
DNA analyses, vseap1-speci¢c sequences are distributed in the
area of 12 kbp, at least. First 120 nucleotides of the cloned
fragment are separated from the downstream sequences by a
region of about 9.5 kbp (data not shown). Probably, the com-
plete vseap1 gene could be expressed as much longer messen-
ger RNA. The possible candidate for such a messenger is the
3.1-kbp hybridizing with vseap1 probe. Sequencing of the 3.1-
kbp RNA, currently in progress, should clarify the structure
of this novel gene. It also might help to understand the role of
vseap1-v-src protein interaction.
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